Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate vs Propofol for Anesthesia Induction in CABG
NCT06068764Phase 4Recruiting
- Sponsor
- Hartford Hospital
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of etomidate in coronary artery disease (CAD) (2 arms), sponsored by Hartford Hospital. Primary endpoint: Vasopressors dose expressed by Noradrenaline Equivalent dose. Started Dec 2023; status: recruiting.
02
Drugs
etomidate
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT06068764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06068764.